Literature DB >> 30106657

The Evolution of Federal Regulation of Human Drugs in the United States: An Historical Essay.

Peter B Hutt1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30106657     DOI: 10.1177/0098858818789421

Source DB:  PubMed          Journal:  Am J Law Med        ISSN: 0098-8588


× No keyword cloud information.
  2 in total

1.  Overcoming Regulatory Aversion to Novel Methods of Evidence Generation.

Authors:  Elodie Baumfeld Andre; Peter K Honig
Journal:  Clin Pharmacol Ther       Date:  2019-11-30       Impact factor: 6.875

2.  COVID-19: A Catalyst to Accelerate Global Regulatory Transformation.

Authors:  Jerry Stewart; Peter Honig; Lina AlJuburi; Deborah Autor; Susan Berger; Patrick Brady; Helen Fitton; Carlos Garner; Michael Garvin; Mathias Hukkelhoven; Robert Kowalski; Sandra Milligan; Liza O'Dowd; Edward Reilly; Khyati Roberts; Andrew S Robertson; Mark Taisey; Roopal Thakkar; Karin Van Baelen; Max Wegner
Journal:  Clin Pharmacol Ther       Date:  2020-09-29       Impact factor: 6.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.